OCT 18, 2016 1:00 PM PDT

Human Neural Organoids: "NexGen" Predictive and Personalized Regenerative Medicine Models of Brain Diseases

Speaker

Abstract
Induced pluripotent stem cells derived from patient cells have emerged as complementary tools to study human neurological disorders.  Neurxstem Inc has generated human iPSC-derived synthetic neural organoids (Neural Organoid PlatformTM) which exhibit a remarkable level of development that morphologically resembles a nearly complete human central nervous system at ~5 weeks in development in utero, but after ~12 weeks in culture in vitro.  These synthetic organoids express a complex milieu of markers characteristic of nearly all types of neurons in the human embryonic central nervous system, as well as cells that are astrocytic, oligodendritic, microglial, and vascular in lineage.  Our analysis supports the formation of all the major regions of the central nervous system including the retina, cortex, midbrain, brain stem and the spinal cord in a single complete neural organoid and is the first time this milestone in human brain organogenesis has been achieved. Using Neurxstem’s proprietary process, we have now engineered synthetic neural organoids from Alzheimer’s disease and tuberous sclerosis patient skin cells. Whole genome transcriptomic shows close genotype-clinical phenotype correlations.

This success strongly suggests that Neurxstem’s Neural Organoid PlatformTM has a multitude of future applications to study neurodegenerative diseases (Alzheimer’s and Parkinsons’s disease, ALS, and MS), neurodevelopmental disorders (autism), and neuropsychiatric disorders (Post Traumatic Stress Disorder (PTSD), bipolar and schizophrenia).

The Neural Organoid PlatformTM is also useful to study the effect of nutrition and environmental toxins on prenatal brain development.

Future exciting applications include assessing effects of changes in gravity and geomagnetic fields on prenatal development of the human brain for space explorations and colonization of new planets.

Methods: We characterize neural organoid responses to genetic or environmental perturbations at the molecular, cellular and structural level using transcriptomics, immunohisto-chemistry, and 3D whole brain imaging. 

Results: Neurxstem has generated human iPSC-derived synthetic Neural Organoid Platforms which exhibit a remarkable level of development that morphologically resembles a nearly complete human embryonic central nervous system at ~5 week in utero development, but after ~12 weeks in culture in vitro.  Using our proprietary process, we have engineered neural organoids from Alzheimer’s disease and tuberous sclerosis patient skin cells with identified genetic mutations in susceptibility genes.  Our transcriptomics results remarkably show comprehensive and accurate correlation of the dysregulated expression of hundreds of genes previously correlated with the clinical symptoms and/or pathologies of both of these diseases. For Alzheimer’s disease these include genes for lipid homeostasis, inflammation, metal ion homeostasis, and water homeostasis and amyloid peptide beta and tau metabolism. For tuberous sclerosis these include genes for tumor formation, autism, blood pressure regulation, Zn++ ion homeostasis, Pb++ ion toxicity, round worm infections, and cholesterol metabolism among others.

Conclusions: Neurxstem’s “NexGen” synthetic Neural Organoid PlatformTM allows the use of whole genome transcriptomic “digitization” of the gene expression response of the models to genetic or environmental perturbations of human brain physiology and thus accurately predict susceptibility to brain disease.
 

Show Resources
You May Also Like
JAN 23, 2020 9:00 AM PST
C.E. CREDITS
JAN 23, 2020 9:00 AM PST
DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
APR 07, 2020 8:00 AM PDT
C.E. CREDITS
APR 07, 2020 8:00 AM PDT
DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
FEB 26, 2020 9:00 AM PST
C.E. CREDITS
FEB 26, 2020 9:00 AM PST
DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
JUN 09, 2020 3:00 PM CEST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
JUN 09, 2020 3:00 PM CEST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
DATE: June 9, 2020 TIME: 6am PT, 9am ET, 3pm CEST The importance of disposable plastic consumables and their overall impact on the experimental workflow of qPCR has been taken into considera...
MAY 08, 2020 10:00 AM PDT
C.E. CREDITS
MAY 08, 2020 10:00 AM PDT
DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
JUN 23, 2020 10:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
JUN 23, 2020 10:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
Loading Comments...
Show Resources